ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TRUP vs CSTL // NET PROFIT MARGIN

Trupanion Inc. (NASDAQ) VS. Castle Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: TRUP 8 — CSTL 2
▲ NET PROFIT MARGIN LEADER: TRUP
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRUP VS. CSTL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TRUP CSTL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.10% 79.40% -63.30 CSTL /gross-margins <GO>
Return on Invested Capital (ROIC) 3.10% -9.30% +12.40 TRUP /roic <GO>
EV/EBITDA & P/E Valuation 49.8x — — TIE /valuation <GO>
Free Cash Flow Yield 5.69% 2.41% +3.28 TRUP /fcf-yield <GO>
Operating Margin 1.00% -12.40% +13.40 TRUP /operating-margins <GO>
Net Profit Margin ACTIVE 1.40% -7.00% +8.40 TRUP /net-margins <GO>
Revenue Growth (YoY) 11.90% 3.70% +8.20 TRUP /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.17 6.97 -3.80 CSTL /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 TRUP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.4 60.9 +6.54 TRUP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 63.4x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.32B $1.18B $148.1M TRUP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TRUP REV CSTL REV TRUP GROSS % CSTL GROSS % TRUP FCF CSTL FCF
FY 2025 $1.44B $344.2M 16.1% 79.4% $75.4M $28.3M
FY 2024 $1.29B $332.1M 13.9% 81.9% $38.6M $36.5M
FY 2023 $1.11B $219.8M — — $18.6M -$5.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRUP // BETA —
CSTL // BETA —